Compare EDIT & DIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EDIT | DIN |
|---|---|---|
| Founded | 2013 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 432.8M | 399.8M |
| IPO Year | 2016 | 1994 |
| Metric | EDIT | DIN |
|---|---|---|
| Price | $2.95 | $35.84 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 7 |
| Target Price | $5.30 | ★ $29.00 |
| AVG Volume (30 Days) | ★ 1.5M | 239.7K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.78% |
| EPS Growth | ★ 37.50 | N/A |
| EPS | N/A | ★ 0.92 |
| Revenue | $31,937,000.00 | ★ $879,300,000.00 |
| Revenue This Year | N/A | $3.61 |
| Revenue Next Year | N/A | $0.64 |
| P/E Ratio | ★ N/A | $38.80 |
| Revenue Growth | ★ 132.64 | 8.25 |
| 52 Week Low | $1.66 | $20.55 |
| 52 Week High | $4.54 | $39.68 |
| Indicator | EDIT | DIN |
|---|---|---|
| Relative Strength Index (RSI) | 54.87 | 55.07 |
| Support Level | $2.40 | $33.50 |
| Resistance Level | $3.27 | $36.38 |
| Average True Range (ATR) | 0.15 | 1.42 |
| MACD | 0.03 | -0.06 |
| Stochastic Oscillator | 73.39 | 79.76 |
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.
Dine Brands Global Inc owns and franchises thousands of restaurants under the International House of Pancakes (IHOP), Applebee's Neighborhood Grill + Bar (Applebee's), and the Fuzzy's Taco Shop (Fuzzy's) names. The company conducts its business through three reportable segments: Franchise, Company-owned restaurants, and Rental. The majority of its revenue is generated from the Franchise segment, which consists of IHOP, Applebee's, and Fuzzy's franchise operations and generates revenue mainly from royalties and advertising fees from several IHOP, Applebee's, and Fuzzy's franchised restaurants, in addition to revenues from the sale of proprietary IHOP and Fuzzy's products to its franchisees. Geographically, the majority of the company's revenues is generated from its domestic market.